Clinical Trial Update: Validation of 70-gene MammaPrint Profile in Japanese Population

View source ↗

Summary

This study reports validation of the 70-gene MammaPrint breast cancer prognostic profile in a Japanese population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Agendia | Conditions: Breast Cancer | Status: COMPLETED